Clinical trial
A Multicenter, Randomized Study of the Sirolimus-Eluting Bx VELOCITY® BALLOON Expandable Stent vs. Intravascular Brachytherapy in the Treatment of Patients With In-Stent Restenotic Coronary Artery Lesions
NCT00231257 is registered in ClinicalTrials.gov with Cordis US Corp. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized Study of the Sirolimus-Eluting Bx VELOCITY® BALLOON Expandable Stent vs. Intravascular Brachytherapy in the Treatment of Patients With In-Stent Restenotic Coronary Artery Lesions
- Lead sponsor
- Cordis US Corp.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 28, 2003
- Completion date
- September 30, 2009
- Enrollment
- 384 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
in-stent restenosis